Romande Energie SA / Key word(s): Miscellaneous Romande Energie Ventures presents its gems 28.03.2024 / 13:00 CET/CEST Dear Sir or Madam Please find attached copy of our press release: Contact for media representatives Contact for Investor Relations (IR) Michèle Cassani René Lauckner Spokesperson Head of Group Treasury Phone: +41 (0)21 802 95 67 Phone: +41 (0)21 802 95 24 Email: Email: End of Media Release Language: English Company: Romande Energie SA Rue de Lausanne 1110 Morges Switz...
Laxxon Medical to Participate in 23rd Annual Needham Virtual Health Conference New York, 03/28/2024 / 08:00, EST/EDT - EQS Newswire - Laxxon Medical NEW YORK, NY / ACCESSWIRE / March 28, 2024 / , a leading pharma-technology company pioneering a new generation of advanced pharmaceuticals, announced today their participation as a private company in the 23rd Annual Needham Virtual Healthcare Conference on April 8-11, 2024.Helmut Kerschbaumer, CEO/Chairman, and Alexander Ruckdaeschel, Chief Strategy Officer, will hold one-on-one meetings with institutional, private equity, and venture capital i...
Romande Energie SA / Mot-clé(s) : Autres Romande Energie Ventures présente ses pépites 28.03.2024 / 13:00 CET/CEST Mesdames, Messieurs, Nous vous prions de bien vouloir trouver, ci-joint, le communiqué de presse intitulé : Contact MEDIAS Contact IR - relations investisseurs Michèle Cassani René Lauckner Porte-parole Trésorier du Groupe Tél. fixe: +41 (0)21 802 95 67 Tél. fixe : +41 (0)21 802 95 24 Email: Email: Fin du communiqué aux médias Langue : Français Entreprise : Romande Energie SA ...
Xometry Introduces Enhanced Teamspace Collaboration Features To Further Expedite Order Management On Its AI-Powered Marketplace Enhanced Collaboration, Order Management Tools And Comprehensive Quote Summary Histories Help Expedite Procurement Within Enterprise Environments NORTH BETHESDA, Md., March 28, 2024 (GLOBE NEWSWIRE) -- Xometry Inc. (NASDAQ: XMTR), connecting enterprise buyers with suppliers of manufacturing services, today introduced enhanced features for its enterprise collaboration software designed to further expedite procurement on its marketplace. “We’re consistently ...
Compass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia Step Down from Board of Directors David Norton Assumes Role of Interim Board Chair while the Company Runs a Global Search for a New Chair LONDON, March 28, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that Board Chair and co-founder George Goldsmith and fellow co-founder Ekaterina Malievskaia have resigned their seats on the company’s b...
Digitalist Group Plc has published Financial Statements of 2023, Report by the Board of Directors, Auditor’s Report, Corporate Governance Statement and Remuneration Report Digitalist Group Plc Stock Exchange Release 28 March 2024 at 14:00 Digitalist Group Plc has published Financial Statements of 2023, Report by the Board of Directors, Auditor’s Report, Corporate Governance Statement and Remuneration Report Digitalist Group Plc has published the Financial Statements of 2023, the Report by the Board of Directors, the Auditor’s Report, the Corporate Governance Sta...
Half-Yearly Results Octopus Future Generations VCT plc Half-Yearly Results Octopus Future Generations VCT plc (‘Future Generations VCT’ or the ‘Company’) is backing businesses that aim to address society’s biggest challenges, providing an opportunity for investors to share in the growth of ambitious, purpose‑driven companies. The Company is managed by Octopus AIF Management Limited (the ‘Manager’), who has delegated investment management to Octopus Investments Limited (‘Octopus’ or ‘Portfolio Manager’) via its investment team Octopus Ventures. The Company today announces...
IMUNON Reports 2023 Financial Results and Provides Business Update Conference Call Begins Today at 10:00 a.m. Eastern Time LAWRENCEVILLE, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- , Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing DNA-mediated immuno-oncology therapies and next-generation vaccines, today reported financial results for the year ended December 31, 2023. The Company also provided an update on its clinical development programs with IMNN-001, a DNA-based interleukin-12 (IL-12) immunotherapy in Phase 2 clinical development for the treatme...
Acrivon Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights WATERTOWN, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biopharmaceutical company developing precision oncology medicines that it matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proprietary proteomics-based patient responder identification platform, Acrivon Predictive Precision Proteomics (AP3), today reported financial results for the...
BrainsWay Announces Positive Results in Late-Life Depression Post-Marketing Analysis Data Published in Leading Peer-Reviewed Publication, Journal of Clinical Medicine JERUSALEM and BURLINGTON, Mass., March 28, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, announced positive results in a recently published post-marketing study of its Deep Transcranial Magnetic Stimulation (Deep TMS™) for the treatment of late-life depression. The data were high...
Daré Bioscience Reports Full Year 2023 Financial Results and Provides Company Update Conference Call and Webcast Today at 4:30 p.m. ET 2023 Highlights and Anticipated 2024 Milestones XACIATO™ (clindamycin phosphate) vaginal gel 2% is available by prescription in the United States to treat bacterial vaginosis under license agreement with commercial collaborator OrganonOvaprene® hormone-free monthly intravaginal contraceptive candidate pivotal Phase 3 contraceptive efficacy study recruiting across the United StatesSildenafil Cream, 3.6% topical formulation of sildenafil being developed to ...
Indaptus Therapeutics to Present at the MedInvest Biotech and Pharma Investor Conference NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, announces today that its CEO, Jeffrey Meckler will present a corporate overview at the MedInvest Biotech & Pharma Investor Conference. The conference is being held on April 3 - 4, 2024 at Cooley Law, 55 Hudson Yards, New York, NY 10001. Presentation Date: April 3, 2024Time: 9:55am ETWebcast Link: “W...
Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs FDA feedback following the Company’s submission of a Pre-IND briefing package improves clarity on regulatory requirements for Phase 2b influenza A clinical trial with oral CC-42344, a broad-spectrum PB2 inhibitorTopline data expected in 2024 from Phase 2a influenza A human challenge study and Phase 1 study with oral CDI-988, the first potential dual coronavirus-norovirus oral antiviralInitiation of Phase 1 study expected in 2024 with inhaled CC-42344, a potential influenza treatme...
WORKSPORT ANNOUNCES RECEIPT OF SOLAR PANELS REQUIRED TO BEGIN PRODUCTION OF HIGHLY ANTICIPATED SOLIS SOLAR TONNEAU COVER West Seneca, New York, March 28, 2024 (GLOBE NEWSWIRE) -- Worksport Ltd. (NASDAQ: WKSP), an innovative automotive accessory manufacturer dedicated to developing clean energy solutions, is thrilled to announce the arrival of a large quantity of custom solar panels, which are required to begin production of the highly anticipated at the Company's New York State manufacturing facility. This milestone marks a significant step forward, allowing the Company to begin initial ...
4DMT Announces Update on Regulatory Interactions and Development Path for 4D-710 for Treatment of Cystic Fibrosis Conducted initial pivotal study interactions with the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA); Company has clear registration path for 4D-710 for treatment of cystic fibrosis (CF) lung disease in people with CF (pwCF) who are ineligible for or cannot tolerate approved CF modulator therapies AEROW clinical trial Phase 2 Expansion Cohort dose selection and initiation expected in Q2 2024, with pivotal trial initiation anticipated in H2 2025Initi...
Digitalist Group Oyj:n vuoden 2023 tilinpäätös, hallituksen toimintakertomus, tilintarkastuskertomus, selvitys hallinto- ja ohjausjärjestelmästä sekä palkitsemisraportti on julkaistu Digitalist Group Oyj Pörssitiedote 28.3.2024 klo 14:00 Digitalist Group Oyj:n vuoden 2023 tilinpäätös, hallituksen toimintakertomus, tilintarkastuskertomus, selvitys hallinto- ja ohjausjärjestelmästä sekä palkitsemisraportti on julkaistu Digitalist Group Oyj on julkaissut vuoden 2023 tilinpäätöksen, hallituksen toimintakertomuksen, tilintarkastuskertomuksen, selvityksen hallinto- ja ohjausjärje...
Breckenridge Brewery Announces Special Denver Nuggets Championship Edition Mile High City Golden Ale A Special Brew Celebrating Denver's Champions with Nostalgic Packaging BRECKENRIDGE, Colo., March 28, 2024 (GLOBE NEWSWIRE) -- ("Breckenridge" or the "Brewery"), a pioneer in Colorado's craft beer scene, and a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), announced today an exciting partnership with the Denver Nuggets to launch a celebratory beer the ‘’. This launch not only marks a unique collaboration celebrating the Nuggets' recent NBA championship triumph but als...
Aqua Metals Announces Participation in Upcoming Investor Conferences RENO, Nev., March 28, 2024 (GLOBE NEWSWIRE) -- Aqua Metals, Inc. (NASDAQ: AQMS), a pioneer in sustainable lithium-ion battery recycling, today announced that Steve Cotton, President & Chief Executive Officer, and Judd Merrill, Chief Financial Officer, will participate in the following investor conferences during April 2024. Gabelli Funds 10th Annual Waste & Sustainability Symposium, April 4, 2024, Virtual: Mr. Cotton and Mr. Merrill will join a live webcast presentation at 2:45 p.m. ET. The webcast link can be accessed ...
Vocodia Launches Pilot Program with Major Utility Provider Company’s Conversational AI to Provide 3rd Party Verification for Switching Energy Providers CHICAGO, March 28, 2024 (GLOBE NEWSWIRE) -- Vocodia Holdings Corp. (CBOE: VHAI) ("Vocodia" or the "Company"), an AI software company that builds practical AI functions, today announced that it has signed an agreement with a large utility services company to launch a pilot program for third party verification to switch energy providers. Vocodia’s solutions can automate this labor intensive function by deploying its scalable enterprise-le...
Agrify Corporation Announces Turnkey Hydrocarbon Extraction Equipment Contract with Connecticut-Based Company New England Edibles, dba SoundView TROY, Mich., March 28, 2024 (GLOBE NEWSWIRE) -- Agrify Corporation (Nasdaq: AGFY) (“Agrify” or the “Company”), a leading provider of innovative cultivation and extraction solutions for the cannabis industry, today announced the signing of a Turnkey Hydrocarbon Extraction and Lab Equipment Package with New England Edibles, dba SoundView, (“SoundView” or the “Customer”), a licensed operator based in Bristol, CT. SoundView has purchased Agrify’s Tu...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.